Sign in

CIK 0000842023

  • Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
Operating
EIN
411427402
Phone
+1 612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
  1. 4 Open-market sale Chief Executive Officer sold 33,031 shares at an average $212.60 ($7,022,524)
  2. 4 Grant or award Director acquired 147 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale SVP - Novus Biologicals sold 3,117 shares at $215.00 ($670,155)
  5. 4 Open-market sale Director sold 5,000 shares at $203.67 ($1,018,346)
  6. 4 Open-market sale SVP - General Counsel sold 5,400 shares at $200.00 ($1,080,000)
  7. 4 Option exercise President, Diagnostics & Genom acquired 1,667 shares (option exercise)
  8. 4 Open-market sale Chief Financial Officer sold 35,000 shares at $203.08 ($7,107,681)
  9. 4 Grant or award Director acquired 514 shares (grant or award)
  10. 4 Grant or award Director acquired 514 shares (grant or award)
  11. 4 Grant or award Director acquired 514 shares (grant or award)
  12. 4 Grant or award Director acquired 514 shares (grant or award)
  13. 4 Grant or award Director acquired 514 shares (grant or award)
  14. 4 Grant or award Director acquired 514 shares (grant or award)
  15. 4 Grant or award Director acquired 514 shares (grant or award)
  16. 4 Shares withheld for taxes Chief Executive Officer gave up 1,338 shares (to pay taxes)
  17. 4 Open-market sale Director sold 5,000 shares at $188.47 ($942,334)
  18. 4 Open-market sale Director sold 10,000 shares at $187.92 ($1,879,173)
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale Director sold 5,000 shares at $176.94 ($884,675)

Page 16 of 35 · 695 filings